A new system for fast and affordable DNA sequencing
High-Throughput DNA Sequencing System
This study is about getting a new high-tech machine that will help scientists at Dana-Farber Cancer Institute quickly and affordably look at genes and understand how they work, which could lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10851325 on NIH RePORTER |
What this research studies
This research focuses on acquiring a NovaSeq X Plus system to enhance the capabilities of the Molecular Biology Core Facilities at the Dana-Farber Cancer Institute. The new system will enable rapid and cost-effective whole genome sequencing, methylation profiling, and single-cell genomics. By improving access to advanced genomic technologies, this project aims to support a wide range of molecular biology applications, making it easier for researchers to conduct large-scale studies. Patients may benefit from the enhanced understanding of their genetic information through improved research outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals requiring detailed genomic analysis for cancer or other genetic conditions.
Not a fit: Patients who do not require genomic testing or those with conditions not related to genetic factors may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with faster and more affordable access to comprehensive genomic testing.
How similar studies have performed: Previous research has shown success with similar high-throughput sequencing technologies, indicating a strong potential for impactful outcomes.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Herbert, Zachary T — Dana-Farber Cancer Inst
- Study coordinator: Herbert, Zachary T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.